George Soros’s Haemonetics HAE Stock Holding History

George Soros’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,200	Closed	-$3.69M	–	267
2021 Q1	$3.69M	Buy	+33,200	New	+$4.11M	0.07%	146

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

George Soros's HAE Position: Q2 2021 in Review

George Soros sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 33,200 shares — an estimated $3.69M sold.

George Soros first reported a position in HAE in Q1 2021 and held it in 1 quarter. The position peaked at $3.69M in Q1 2021. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

George Soros reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
George Soros sold 33,200 Haemonetics shares in Q2 2021, an estimated $3.69M.
George Soros first reported a position in Haemonetics in Q1 2021 and held it in 1 quarter.
George Soros's Haemonetics position peaked at $3.69M in Q1 2021.
258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Soros Fund Management's 13F filing for Q2 2021, filed 13 Aug 2021.